To determine whether FBXO7-mediated downregulation of PRMT1 protein level is attributed to ubiquitin-proteasome degradation, FBXO7 KD HCC cells were treated with MG132 or bortezomib. Here, FBXO7 is linked to hepatocellular carcinoma.